Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Abbreviation
HHSOIG
Agencies
Department of Health & Human Services
Federal Agency
Yes
Location

United States

What to Report to the OIG Hotline
The U.S. Department of Health and Human Services (HHS) Office of Inspector General's (OIG) mission is to protect the integrity of HHS programs as well as the health and welfare of program beneficiaries. In doing so, we rely on complaints by HHS employees, contractors, subcontractors, grantees and subgrantees (i.e. whistleblowers) who report fraud, waste, abuse or mismanagement in HHS programs. We also review and investigate reports of whistleblower retaliation. If you would like more information on what kinds of complaints our OIG investigates, please visit our website at https://oig.hhs.gov/fraud/report-fraud/before-you-submit.asp. There you will find a list of things you should know before submitting a complaint to the OIG. If you would like more information on the types of whistleblowers protected by the OIG, please visit our whistleblower protection page at https://oig.hhs.gov/fraud/report-fraud/whistleblower.asp. If you are a whistleblower and wish to report fraud, waste, abuse or mismanagement in HHS programs, or you wish to report whistleblower retaliation, please visit our Hotline at https://oig.hhs.gov/fraud/report-fraud/index.asp.
What Not to Report to the OIG Hotline
  • Issues about Medicare policy, coverage, billing claims or appeals
  • Lost or stolen Medicare card
  • Allegations by HHS employees of discrimination on the basis of race, gender, ethnicity, religion or sexual preference
  • Allegations by employees or applicants concerning prohibited personnel practices; or Hatch Act violations
  • Appeals of administrative decisions made by HHS agencies, grantees or contractors, including Medicare payment decisions and contract or grant awards
  • Appeals of judicial decisions by federal or state courts involving HHS programs
  • Complaints of failure to safeguard medical information, i.e. HIPAA violations
  • Customer service complaints involving HHS employees, grantees or contractors
  • Allegations of identity theft unrelated to HHS programs
  • Disability fraud
  • SNAP/Food Stamp Fraud
  • Self-Disclosures

New Jersey Laboratory and Owner/CEO Agree to Pay $13 Million to Settle Allegations of Kickbacks and Unnecessary Testing

New Jersey Laboratory and Owner/CEO Agree to Pay $13 Million to Settle Allegations of Kickbacks and Unnecessary Testing
Article Type
Investigative Press Release
Publish Date

New Jersey Laboratory and Owner/CEO Agree to Pay $13 Million to Settle Allegations of Kickbacks and Unnecessary Testing

Pharmaceutical Company Ultragenyx Agrees to Pay $6 Million for Allegedly Paying Kickbacks to Induce Claims for its Drug Crysvita

Pharmaceutical Company Ultragenyx Agrees to Pay $6 Million for Allegedly Paying Kickbacks to Induce Claims for its Drug Crysvita
Article Type
Investigative Press Release
Publish Date

Pharmaceutical Company Ultragenyx Agrees to Pay $6 Million for Allegedly Paying Kickbacks to Induce Claims for its Drug Crysvita

United States Reaches $9.1 Million Civil Settlement with Total Access Urgent Care Over False Claims Allegations

United States Reaches $9.1 Million Civil Settlement with Total Access Urgent Care Over False Claims Allegations
Article Type
Investigative Press Release
Publish Date

United States Reaches $9.1 Million Civil Settlement with Total Access Urgent Care Over False Claims Allegations

United Memorial Medical Center to pay $2M plus additional payments for allegedly causing false claims related to excessive cost outlier payments and double billing for Covid-19 tests

United Memorial Medical Center to pay $2M plus additional payments for allegedly causing false claims related to excessive cost outlier payments and double billing for Covid-19 tests
Article Type
Investigative Press Release
Publish Date

United Memorial Medical Center to pay $2M plus additional payments for allegedly causing false claims related to excessive cost outlier payments and double billing for Covid-19 tests

Former Chief Operating Officer of Suburban Chicago Covid-19 Testing Kit Company Charged With Embezzling at Least $1.8 Million in Company Funds

Former Chief Operating Officer of Suburban Chicago Covid-19 Testing Kit Company Charged With Embezzling at Least $1.8 Million in Company Funds
Article Type
Investigative Press Release
Publish Date

Former Chief Operating Officer of Suburban Chicago Covid-19 Testing Kit Company Charged With Embezzling at Least $1.8 Million in Company Funds

Subscribe to Department of Health & Human Services OIG